
William Wells-Gatnik, MD
@willwellsgatnik
Incoming IM PGY-1 at TTUHSC - El Paso 🩺 | Junior editorial board member at the Journal of Headache and Pain | Social Media Editor at SNCCM
ID: 1550118979657641984
21-07-2022 14:02:31
40 Tweet
72 Followers
131 Following



Although CGRP mAbs have changed the treatment of migraine drastically, there is plenty of room for innovation! Check out our recent review summarizing the most promising drugs in clinical trials for migraine. Dilara Onan Paolo Martelletti tandfonline.com/doi/abs/10.108…




To switch or not to switch, that is the question! Check out our review assessing evidence supporting and opposing switching CGRP MoAbs in individuals that did not receive adequate migraine improvement following initial CGRP MoAb therapy! Paolo Martelletti doi.org/10.1080/147125…



How comfortable are you with prescribing gepants for the treatment of migraine? If your answer isn’t “extremely!” Check out our review discussing the innovative and flexible roles of rimegepant and atogepant. pubmed.ncbi.nlm.nih.gov/39264231/ Paolo Martelletti Lanfranco Pellesi


Recognizing the hallmarks of migraine and the features of single patients enables prescribing specific pharmacological and non-pharmacological treatments. Paolo Martelletti Matilde Leonardi EloĂsa Rubio B Marta Waliszewska-Prosół William Wells-Gatnik, MD …alofheadacheandpain.biomedcentral.com/articles/10.11…


Extremely proud and grateful of being part of this gigantic endeavor European Headache Federation Wolfson SPaRC Institute of Psychiatry, Psychology & Neuroscience rdcu.be/dYXz1





📢Good News! Happy to announce that SN Comprehensive Clinical Medicine has been accepted for SCOPUS Elsevier | Scopus Paolo Martelletti William Wells-Gatnik, MD Springer Springer Nature link.springer.com/journal/42399
